Nakagawa Hirotaka, Mitchell Kristen, Sussman Walter I
Department of Orthopedics & Rehabilitation, Tufts Medical Center 800 Washington Street, Boston, MA 02111, USA.
Boston Sports & Biologics, 20 Walnut St. Suite 14, Wellesley, MA 02481, USA.
Regen Med. 2024 Nov;19(11):529-539. doi: 10.1080/17460751.2024.2422193. Epub 2024 Nov 26.
Metatarsal head stress fractures pose treatment challenges with no established consensus. In this article, we introduce a percutaneous treatment involving autologous bone marrow aspirate concentrate (BMAC) injection without surgical fixation in a 21-year-old basketball player with a stress fracture of the right fifth metatarsal head. He underwent this procedure following unsuccessful 8 months of conservative treatment. Twelve weeks after the procedure, a CT scan confirmed complete healing, facilitating his return to sports. This innovative method offers a promising alternative, avoiding the associated morbidity of surgical intervention. Further research, comparing refracture rates with surgical options, is warranted to inform treatment decisions for this uncommon injury and validate the efficacy of percutaneous BMAC injection.
跖骨头应力性骨折带来了治疗挑战，目前尚无既定的共识。在本文中，我们介绍了一种经皮治疗方法，该方法是在一名21岁的右第五跖骨头应力性骨折的篮球运动员身上进行自体骨髓抽吸浓缩物（BMAC）注射，而无需手术固定。在经过8个月的保守治疗失败后，他接受了此手术。手术后12周，CT扫描证实完全愈合，使他能够重返运动。这种创新方法提供了一种有前景的替代方案，避免了手术干预相关的发病率。有必要进行进一步的研究，将再骨折率与手术选择进行比较，以为这种罕见损伤的治疗决策提供依据，并验证经皮BMAC注射的疗效。
